You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

ABL

Showing 1 - 25 of 1,288
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

ABL90 FLEX PLUS Clinical Precision Study for 15 Parameters in

Recruiting
  • Diagnostic Test
  • ABL90 FLEX PLUS analyser running SW3.5 MR2.
  • Copenhagen, Østerbro, Denmark
    Tejs Jansen
Mar 26, 2023

ABL90 FLEX PLUS Clinical Precision Study for ctBil and FHbF

Recruiting
  • Blood Tests
  • ABL90 FLEX PLUS analyser running SW3.5 MR2.
  • Copenhagen, Brønshøj, Denmark
  • +1 more
Mar 25, 2023

Congenital Heart Disease Trial in Saint Louis (method comparison)

Recruiting
  • Congenital Heart Disease
  • method comparison
  • Saint Louis, Missouri
    St Louis Children's Hospital
Oct 9, 2023

Advanced Solid Tumor Trial in Seongnam, Seoul (ABL103)

Recruiting
  • Advanced Solid Tumor
  • Seongnam, Seoul, Korea, Republic of
  • +2 more
Nov 13, 2023

Healthy Trial in Austin (ABL301, Placebo)

Recruiting
  • Healthy
  • Austin, Texas
    PPD Development, LP
Mar 6, 2023

Diagnostic Test Trial in Sacramento (Measuring of analytes)

Recruiting
  • Diagnostic Test
  • Measuring of analytes
  • Sacramento, California
    UC Davis
Oct 9, 2023

Chronic Phase Chronic Myelogenous Leukemia, Philadelphia Chromosome Positive, BCR-ABL1 Positive Chronic Myelogenous Leukemia

Recruiting
  • Chronic Phase Chronic Myelogenous Leukemia
  • +3 more
  • Houston, Texas
    M D Anderson Cancer Center
Aug 11, 2022

Chronic Myelogenous Leukemia, Philadelphia Chromosome-positive Acute Lymphoblastic Leukemia Trial in Worldwide (ABL001, ABL001 +

Active, not recruiting
  • Chronic Myelogenous Leukemia
  • Philadelphia Chromosome-positive Acute Lymphoblastic Leukemia
  • Boston, Massachusetts
  • +18 more
Jan 19, 2023

Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Acute Lymphoblastic Leukemia, BCR-ABL1 Fusion Protein

Recruiting
  • Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
  • +7 more
  • Blinatumomab
  • +3 more
  • Houston, Texas
    M D Anderson Cancer Center
Dec 31, 2022

Myeloproliferative Tumor, Chronic Phase Chronic Myelogenous Leukemia, Chronic Myeloid Leukemia Trial in San Francisco (Online

Recruiting
  • Myeloproliferative Neoplasm
  • +2 more
  • Online Mindfulness Meditation
  • Internet-Based Webinars
  • San Francisco, California
    University of California San Francisco
Aug 9, 2022

Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Acute Myeloid Leukemia, Blast Phase Chronic Myelogenous

Recruiting
  • Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
  • +6 more
  • Houston, Texas
    M D Anderson Cancer Center
Oct 31, 2022

Outcomes in Chronic Myeloid Leukaemia

Completed
  • Chronic Myeloid Leukaemia
    • York, United Kingdom
      Haematological Malignancy Research Network
    Jun 7, 2023

    B-cell Acute Lymphoblastic Leukemia, Chronic Myeloid Leukemia (CML) in Lymphoid Blast Crisis, Philadelphia Chromosome Positive

    Recruiting
    • B-cell Acute Lymphoblastic Leukemia
    • +2 more
    • Chicago, Illinois
    • +5 more
    Dec 27, 2021

    Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Philadelphia Chromosome Positive, Recurrent Acute Lymphoblastic

    Active, not recruiting
    • Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
    • +6 more
    • Houston, Texas
      M D Anderson Cancer Center
    Dec 2, 2022

    Myeloproliferative Tumor Trial in Toronto (Azacitidine, Venetoclax)

    Not yet recruiting
    • Myeloproliferative Neoplasm
    • Toronto, Ontario, Canada
      Princess Margaret Cancer Centre
    Apr 12, 2022

    Asciminib RMP Study

    Not yet recruiting
    • Chronic Myeloid Leukemia
    • Asciminib
    • (no location specified)
    Jul 5, 2023

    Chronic Myeloid Leukemia, BCR/ABL-Positive, in Remission Trial (Asciminib, Imatinib)

    Not yet recruiting
    • Chronic Myeloid Leukemia, BCR/ABL-Positive, in Remission
    • (no location specified)
    Jun 7, 2022

    Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Philadelphia Chromosome Positive, BCR-ABL1 Positive Chronic

    Recruiting
    • Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
    • Philadelphia Chromosome Positive, BCR-ABL1 Positive Chronic Myelogenous Leukemia
    • Houston, Texas
      M D Anderson Cancer Center
    Jun 24, 2022

    Philadelphia Chromosome Negative, BCR-ABL1 Positive Chronic Myelogenous Leukemia Trial in Houston (Asciminib)

    Recruiting
    • Philadelphia Chromosome Negative, BCR-ABL1 Positive Chronic Myelogenous Leukemia
    • Houston, Texas
      M D Anderson Cancer Center
    Feb 1, 2022

    Chronic Myeloid Leukemia, BCR/ABL-Positive Trial in Taipei

    Not yet recruiting
    • Chronic Myeloid Leukemia, BCR/ABL-Positive
      • Taipei, Taiwan
        National Taiwan University Hospital
      Jul 24, 2022

      Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Philadelphia Chromosome Positive, BCR-ABL1 Positive Chronic

      Recruiting
      • Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
      • +2 more
      • Laboratory Biomarker Analysis
      • +2 more
      • Houston, Texas
        M D Anderson Cancer Center
      Jun 15, 2022

      Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Aplastic Anemia Trial in Columbus (Health Promotion and Education, Medical

      Active, not recruiting
      • Acute Lymphoblastic Leukemia
      • +11 more
      • Health Promotion and Education
      • +3 more
      • Columbus, Ohio
        Ohio State University Comprehensive Cancer Center
      Jul 24, 2023

      Acute Myeloid Leukemia, Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Cord Blood Transplant Recipient Trial in Houston

      Recruiting
      • Acute Myeloid Leukemia
      • +4 more
      • Recombinant Interleukin-7
      • Houston, Texas
        M D Anderson Cancer Center
      Jan 26, 2023

      B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1, Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive,

      Completed
      • B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1
      • +6 more
      • Houston, Texas
        M D Anderson Cancer Center
      Mar 25, 2022

      Chronic Phase Chronic Myelogenous Leukemia Trial in Detroit, Milwaukee (Asciminib, Imatinib)

      Recruiting
      • Chronic Phase Chronic Myelogenous Leukemia
      • Detroit, Michigan
      • +1 more
      May 3, 2022